State Of Alaska, Department Of Revenue Arcus Biosciences, Inc. Transaction History
State Of Alaska, Department Of Revenue
- $9.79 Billion
- Q3 2025
A detailed history of State Of Alaska, Department Of Revenue transactions in Arcus Biosciences, Inc. stock. As of the latest transaction made, State Of Alaska, Department Of Revenue holds 34,809 shares of RCUS stock, worth $702,793. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,809
Previous 40,322
13.67%
Holding current value
$702,793
Previous $327,000
44.65%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding RCUS
# of Institutions
211Shares Held
67MCall Options Held
3.18MPut Options Held
167K-
Black Rock Inc. New York, NY9.76MShares$197 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.56MShares$132 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct5.97MShares$120 Million0.11% of portfolio
-
Woodline Partners LP San Francisco, CA4MShares$80.8 Million0.19% of portfolio
-
Suvretta Capital Management, LLC New York, NY3.69MShares$74.5 Million1.03% of portfolio
About Arcus Biosciences, Inc.
- Ticker RCUS
- Exchange NYSE
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 72,160,000
- Market Cap $1.46B
- Description
- Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. Its product pipeline includes, Etrumadenant, a dual A2a/A2b adenosine receptor antagonist, which is in a Phase 1b/2 clinical trial; and Zimberelimab, an anti-PD-1 antibody that is in Phase 1b clinical trial for ...